U.S. Could Have Had Many More Doses of Monkeypox Vaccine This Year

U.S. Dragged Feet on Getting Monkeypox Vax Into Vials: NYT

The government owns more than 16 million doses of the vaccine in bulk but failed to ask for it to be bottled for distribution quickly enough.

U.S. Slow To Ask For Monkeypox Vaccines, Adding Months To Delivery Schedule: Report

Millions of vaccines on order likely won't be delivered until 2023.

U.S. could have had many more doses of monkeypox vaccine this year

The Department of Health and Human Services delayed asking the manufacturer to process the bulk vaccine the government already owned into vials.

U.S. Could Have Had Many More Doses of Monkeypox Vaccine

“The shortage of vaccines to combat a fast-growing monkeypox outbreak was caused in part because the Department of Health and Human Services failed early on to ask that bulk stocks of the vaccine it already owned be bottled for distribution,“ the New York Times reports.“By the time the federal government placed its orders, the vaccine’s Denmark-based manufacturer, Bavarian Nordic, had booked other clients and was unable to do the work for months…

U.S. Regulators Defend Requiring More Data On Monkeypox Drug

As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday defended their decision to require human trial data to show that SIGA Technologies' experimental drug TPOXX is safe and effective to treat the virus.

U.S. regulators defend requiring more data on monkeypox drug

As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday defended their decision to require human trial data to show that SIGA Technologies' experimental drug TPOXX is safe and effective to treat the virus.